Ship Healthcare Holdings (3360) AI Stock Analysis

• Market Cap: ¥199.78B
• Dividend Yield: 2.53%
• Average Volume (3M): 301.21K
• Price to Earnings (P/E): 15.2
• Beta (1Y): 0.46
• Revenue Growth: 7.28%
• EPS Growth: 1.72%
• Country: JP
• Employees: 7,793
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 21.54
• Shares Outstanding: 94,350,136
• 10 Day Avg. Volume: 225,940
• 30 Day Avg. Volume: 301,213
• PEG Ratio: 1.29
• Price to Book (P/B): 1.27
• Price to Sales (P/S): 0.28
• P/FCF Ratio: 11.42
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 76 Outperform
• Price Target: ¥2,213.00 ▼(-2.70% Downside)

Ship Healthcare Holdings scores well due to its strong financial performance and positive technical indicators. The company's consistent revenue growth and financial stability are significant strengths. The fair valuation supports the overall score, making it a solid investment in the medical instruments and supplies industry.

Ship Healthcare Holdings Business Overview & Revenue Model

Company Description

Ship Healthcare Holdings (3360) is a leading provider of healthcare services in Japan, specializing in the distribution of medical equipment, pharmaceuticals, and healthcare-related products. The company operates in various sectors including hospital supply, home healthcare, and medical logistics. With a focus on enhancing patient care and improving operational efficiency for healthcare institutions, Ship Healthcare Holdings offers a comprehensive range of products and services that cater to the evolving needs of the healthcare industry.

How the Company Makes Money

Ship Healthcare Holdings generates revenue primarily through the sale and distribution of medical supplies and equipment to hospitals, clinics, and healthcare providers. The company operates on a B2B model, where it partners with manufacturers and suppliers to offer a wide array of products, including surgical instruments, diagnostic equipment, and home healthcare products. Key revenue streams include direct sales of medical products, logistics and supply chain management services, and value-added services such as equipment maintenance and training. Strategic partnerships with healthcare institutions and suppliers enhance their distribution capabilities and market reach, contributing significantly to their earnings.

Ship Healthcare Holdings Financial Statement Overview

Summary

Ship Healthcare Holdings demonstrates strong financial performance with consistent revenue growth, stable profit margins, and effective cash flow management. The reduction in leverage and improved return on equity further enhance its financial stability, despite a slight decrease in cash reserves.

Income Statement

Ship Healthcare Holdings has demonstrated robust revenue growth over the years, with a notable increase from 514.35 billion yen in 2022 to 678.23 billion yen in 2025. The gross profit margin remains stable at around 10%, and the net profit margin improved to approximately 2.23% in 2025. EBIT and EBITDA margins have been consistent, contributing to overall profitability. The company's ability to grow revenue consistently highlights its strong market position and effective business strategy.

Balance Sheet

The balance sheet of Ship Healthcare Holdings shows a healthy equity position, with a debt-to-equity ratio improving from 0.61 in 2020 to 0.25 in 2025, indicating reduced leverage and risk. The equity ratio remains strong, reflecting financial stability. Return on equity has improved, suggesting efficient use of shareholder funds. However, the reduction in cash reserves over time and the presence of debt warrants ongoing monitoring.

Cash Flow

Operating cash flow remains strong, supporting the company's operational needs. Despite fluctuations, free cash flow has shown positive growth, with a notable increase from 8.96 billion yen in 2022 to 16.56 billion yen in 2025. The operating cash flow to net income ratio is favorable, indicating effective cash management. While capital expenditures are well-managed, continuous monitoring of financing activities is recommended.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	686.32B	678.23B	630.99B	572.28B	514.35B	497.16B
Gross Profit	66.79B	66.74B	65.61B	60.62B	53.64B	54.49B
EBITDA	30.68B	32.19B	29.75B	28.61B	26.57B	26.69B
Net Income	14.09B	15.13B	13.79B	12.06B	12.17B	12.28B
Balance Sheet
Total Assets	367.17B	381.70B	386.82B	381.98B	335.07B	334.50B
Cash, Cash Equivalents and Short-Term Investments	80.57B	77.50B	85.07B	80.84B	73.81B	73.91B
Total Debt	31.56B	37.34B	57.93B	73.94B	61.22B	64.96B
Total Liabilities	220.75B	231.42B	244.60B	250.86B	212.76B	219.40B
Stockholders Equity	145.32B	149.08B	139.52B	128.04B	118.29B	111.44B
Cash Flow
Free Cash Flow	0.00	16.56B	28.09B	10.20B	8.96B	14.76B
Operating Cash Flow	0.00	20.38B	31.61B	14.11B	12.43B	19.77B
Investing Cash Flow	0.00	-4.03B	-7.20B	-6.77B	-3.87B	-19.29B
Financing Cash Flow	0.00	-24.62B	-20.48B	-1.02B	-8.84B	-10.46B

Ship Healthcare Holdings Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 2274.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3360, the sentiment is Neutral. The current price of 2274.5 is below the 20-day moving average (MA) of 2318.55, below the 50-day MA of 2288.92, and above the 200-day MA of 2068.85, indicating a neutral trend. The MACD of 11.60 indicates Positive momentum. The RSI at 48.43 is Neutral, neither overbought nor oversold. The STOCH value of 32.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3360.

Ship Healthcare Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3360	―	¥199.78B	15.20	10.03%	2.53%	7.28%	1.72%
7817	―	$192.21B	23.53	6.47%	3.11%	1.96%	22.78%
7730	―	¥144.82B	28.18	―	2.64%	5.10%	-17.80%
7716	―	€179.19B	34.68	4.39%	2.52%	10.98%	-76.45%
8086	―	¥245.13B	42.42	2.49%	2.00%	8.83%	-40.24%
3593	―	$117.07B	95.31	0.78%	1.61%	-2.06%	-79.17%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Ship Healthcare Holdings Corporate Events

Ship Healthcare Completes Treasury Share Acquisition

Ship Healthcare Holdings, Inc. has completed its acquisition of treasury shares as per the resolution passed by its Board of Directors on June 6, 2025. The acquisition included 115,800 common shares at a total price of 267,887,950 yen, conducted through market purchases on the Tokyo Stock Exchange. This move is part of a larger strategy to acquire up to 3,300,000 shares, enhancing the company’s financial flexibility and shareholder value.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen2213.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Acquires Treasury Shares to Optimize Capital Structure

Ship Healthcare Holdings, Inc. announced the acquisition of 598,600 of its own common shares in September 2025, as part of a larger treasury share acquisition plan. This move is part of a strategic effort to optimize capital structure and potentially enhance shareholder value, with a total of 2,215,400 shares acquired by the end of September 2025.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen2213.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Acquires Treasury Shares as Part of Buyback Strategy

Ship Healthcare Holdings, Inc. announced the acquisition of 636,000 treasury shares in August 2025, valued at approximately 1.39 billion yen, as part of a previously announced buyback program. This move is part of a broader strategy to acquire up to 3.3 million shares by the end of 2025, potentially impacting the company’s market positioning and shareholder value.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen2213.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Reports Increased Sales but Declining Profits in Q1 2025

Ship Healthcare Holdings reported a 5.2% increase in net sales for the three months ending June 30, 2025, compared to the same period in 2024. However, the company experienced declines in operating profit, ordinary profit, and profit attributable to owners of the parent, with decreases of 15.8%, 31.0%, and 34.1%, respectively. The financial results indicate challenges in profitability despite increased sales, which may impact the company’s market positioning and stakeholder confidence.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Announces Treasury Share Acquisition

Ship Healthcare Holdings, Inc. has announced the acquisition of 720,800 treasury shares in July 2025, as part of its ongoing share buyback program. This strategic move, conducted through the Tokyo Stock Exchange, aims to enhance shareholder value and optimize the company’s capital structure, reflecting its commitment to financial stability and market confidence.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.